Latest News

Kraft reports its second-quarter earnings next week.

Amex had strong Q2 revenue and earnings growth, but rising expenses are concerning.

Fortis (TSX:FTS) stock looks like a safe, steady, and smart play as AI takes off.

Amid record ETF inflows, niche funds like BBC, LATR, and FMED offer targeted exposure to biotech trials, buy-now-pay-later firms, and disruptive medicine, with notable recent returns.

Favorable trends could drive Delta to even higher altitudes.

Intel's turnaround is just starting, but the stock has fully priced in a complete revival.

The tech company has earnings coming up in a few weeks.

State Street's fund charges just 0.08% annually versus 0.38% for iShares, but the broader portfolio offers 100 holdings versus 60.

Boyd Group Services stock has dropped over 55% from its record high. Here is why this collision repair leader may be set to rise in 2026.

The stock is down 37% this year, but management is raising its full-year guidance.

Getting this wrong could be devastating at tax time.

GM raised profit guidance on steady pricing and strong truck sales, while Mobileye's unit growth masked falling per-system prices and a founder's planned departure.

Smart Care Solutions recently announced two major executive leadership appointments to strengthen its corporate structure. The commercial equipment service

Azul recently announced a transition toward monthly security patch updates for Java enterprise systems. This updated release cadence accelerates threat pro

The stock is trading at a discount over a short-term issue.

In today's competitive digital marketplace, businesses need innovative mobile applications to improve customer engagement, automate operations, and increas

ETFs will keep buying SpaceX even if its stock price continues tumbling.

Astrazeneca (NYSE:AZN) reported first-half 2026 revenue growth of 6% at constant exchange rates, or 11% excluding the effects of generic competition on Farxiga and Brilinta, while core earnings per share increased 11%. The company reiterated its full-year outlook and said it remains confident in its

As the US nutraceutical, functional beverage, and food industries continue to prioritize plant-based and clean-label ingredients, procurement teams are pla

State Street's concentrated 60-stock approach outpaced Fidelity's broader 365-holding fund over five years, though both charge identical 0.08% fees.

The longtime successful retailer has seen its stock price slide over the last couple of months.

Vicor beat earnings estimates with backlog up 145% to $380 million, and Needham kept its Buy rating with a $320 target, implying about 50% upside despite the stock's muted reaction.

This ETF uses a similar strategy but has outperformed the Schwab U.S. Dividend Equity ETF (SCHD) by 3 percentage points annually over the past decade.

The healthcare industry in the USA is rapidly evolving with digital innovation, and mobile applications are becoming a crucial part of modern healthcare de

Ford launches Nike-style Bronco vehicle drops and expands customization offerings to capture a bigger share of the U.S. aftermarket.